Risk Factors Associated with Loss to Follow-Up during Tuberculosis Treatment in the Sanatorium Hospital of Luanda, Angola

Other authors

Institut Català de la Salut

[Vita D] DSS/EMG/FAA-Angola, Vita International Health Agency, London SW8 4EP, UK. Department of Engineering and Technology, Instituto Superior Politécnico de Tecnologias e Ciências (ISPTEC), Luanda, Angola. Instituto Superior Técnico Militar (ISTM), Luanda, Angola. Department of Forensic Science, Geeta University, Panipat, India. [Aznar ML, Martínez-Campreciós J, Molina I] Unitat de Medicina Tropical i Salut Internacional, Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. PROSICS, Barcelona, Spain. [Kansietoko DCMS] Complexo Hospitalar Cardio Pulmonar, Cardeal Dom Alexandre de Nascimento, Luanda, Angola

Vall d'Hebron Barcelona Hospital Campus

Publication date

2024-07-01T11:41:52Z

2024-07-01T11:41:52Z

2024-06-12



Abstract

Food insecurity; Loss to follow-up; Tuberculosis


Inseguretat alimentària; Pèrdua de seguiment; Tuberculosi


Inseguridad alimentaria; Pérdida de seguimiento; Tuberculosis


Background: Tuberculosis (TB) continues to be a serious public health threat that affects the most vulnerable populations. Patients who are lost to follow-up (LTFU) after TB diagnosis still represent one of the biggest challenges to TB control. Method: In this prospective observational study, we aimed to identify and analyse the risk factors associated with LTFU among TB patients who started first-line TB treatment in the Sanatorium Hospital in Luanda. Result: A total of 113 patients with TB (non-multidrug resistant) were included between August 2018 and September 2019. Seventy-six (67.3%) patients were cured, 27 (23.9%) were LTFU, 5 (4.4%) died, 4 (3.5%) were transferred and 1 (0.9%) presented treatment failure. After excluding those who died, were transferred or failed treatment, we observed that severe TB at the time of diagnosis (OR 9.24, 95% CI 2.18-39.04) and food insecurity were significantly associated with LTFU (OR 5.96, 95% CI 1.66-21.41). Conclusions: The findings of our study can contribute to understanding the reasons for the LTFU of patients with TB and can guide policies and facilitate designing measures to allow better adherence and, therefore, greater treatment success.

Document Type

Article


Published version

Language

English

Publisher

MDPI

Related items

Tropical Medicine and Infectious Disease;9(6)

https://doi.org/10.3390/tropicalmed9060131

Recommended citation

This citation was generated automatically.

Rights

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

This item appears in the following Collection(s)